Type of Study:
Endometriosis

Study Length:
Depends on study arm randomized into

Target Age/Sex:
18 to 49 female subjects

Benefits:
Participants will receive at no cost: Study medication and study related procedures. Subject may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain.

To learn more, fill out the form or call 208-557-2991 or 208-557-2924.

Enroll Now

Enroll Now